Mark Feneley

1.8k citations
65 papers · 1.3k indexed · h-index 23
Topics
Prostate Cancer Diagnosis and Treatment (28 papers)Prostate Cancer Treatment and Research (23 papers)Bladder and Urothelial Cancer Treatments (13 papers)

In The Last Decade

Mark Feneley

64 papers receiving 1.3k citations

Peers

Mark Feneley
Comparison fields: 5 of 105
  • Pulmonary and Respiratory Medicine 525
  • Surgery 380
  • Urology 309
  • Molecular Biology 293
  • Rheumatology 205
Replace Kazuhiro Yoshimura with:
Kazuhiro Yoshimura Japan
S. Jacobs United States
Philippe Berthon France
S. Bruce Malkowicz United States
S. Machtens Germany
Jon Oxley United Kingdom
Ying-hao SUN China
Wendy Bruening United States
Martti Nurmi Finland
Mark Feneley relative to Kazuhiro Yoshimura Japan Kazuhiro Yoshimura's profile →
Citations per field
00.5×2.8×
Kazuhiro Yoshimura · 1×
Citations per year

Countries citing papers authored by Mark Feneley

Since Specialization
Citations

This map shows the geographic impact of Mark Feneley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Feneley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Feneley more than expected).

Fields of papers citing papers by Mark Feneley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Feneley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Feneley. The network helps show where Mark Feneley may publish in the future.

Co-authorship network of co-authors of Mark Feneley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Feneley. A scholar is included among the top collaborators of Mark Feneley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Feneley. Mark Feneley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 107
3 43
4 5
5 2
6 69
7 34
8 11
9 6
10 3
11 4
12 13
13 11
14 7
15 28
16 31
17 2
18 11
19 5
20 98

About Mark Feneley

Mark Feneley is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 65 papers that have together received 1.3k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (28 papers), Prostate Cancer Treatment and Research (23 papers) and Bladder and Urothelial Cancer Treatments (13 papers). The work is most often cited by research in Urology (309 citations), Pulmonary and Respiratory Medicine (525 citations) and Rheumatology (205 citations). Mark Feneley has collaborated with scholars based in United Kingdom, United States and Norway. Frequent co-authors include Roger Kirby, James W. Fawcett, Roger J. Keynes, Malcolm Carruthers, Jason Constantinou, John R. Masters, Alex Freeman, John D. Kelly, Patrick C. Walsh and Wei Shen Tan. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026